MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Adrenal Cancer

Active Clinical Trials

Clinical Trial
Biological
  • Status: Recruiting
  • Study Type: Biological
  • Participants: 72
  • Start Date: July 23, 2020
A Phase 1/2 Trial of a Novel Therapeutic Vaccine (EO2401) in Combination With Immune Check Point Blockade, for Treatment of Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 300
  • Start Date: June 25, 2020
Natural History Study of Children and Adults With Adrenocortical Cancer
Clinical Trial
Device
  • Status: Recruiting
  • Study Type: Device
  • Participants: 30
  • Start Date: September 26, 2019
Cone-beam Computed Tomography Guided Percutaneous Cryoablation of Bone Metastases From Endocrine Tumors
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 37
  • Start Date: June 4, 2019
Phase II Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable/Metastatic Adrenocortical Carcinoma
Clinical Trial
Procedure
  • Status: Recruiting
  • Study Type: Procedure
  • Participants: 68
  • Start Date: January 2, 2019
Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations (ITACA Study)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 240
  • Start Date: August 20, 2018
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Participants With Stage I-III Adrenocortical Cancer With High Risk of Recurrence (ADIUVO-2)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 240
  • Start Date: July 1, 2018
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Participants With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 18
  • Start Date: February 26, 2018
A Phase II Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable/Metastatic Adrenocortical Carcinoma
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 25
  • Start Date: January 25, 2018
Multicenter, Prospective, Non-randomized, Phase II Trial Designed to Evaluate the Activity of Cabazitaxel in Patients With Advanced Adreno-Cortical- Carcinoma Progressing After Previous Chemotherapy Lines
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 57
  • Start Date: December 28, 2017
A Phase II Study of Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 1150
  • Start Date: December 14, 2017
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: September 22, 2017
Phase II Trial of Surgical Resection and Heated Intraperitoneal Peritoneal Chemotherapy (HIPEC) for Adrenocortical Carcinoma
Showing 1–12 of 31 Clinical Trials
Next